During an active infection with human cytomegalovirus (HCMV), viral antigen is consistently present in peripheral blood leukocytes. Two monoclonal antibodies (MAbs), CMV-C10 and CMV-C11, are commonly used in the HCMV antigenaemia assay to detect these cells in the peripheral blood of patients suspected of having an active HCMV infection. We demonstrate that the viral antigen detected by these MAbs is the viral structural protein pp65 and not an immediate early antigen as previously reported. Furthermore, significantly fewer leukocytes were found to be positive with MAbs specific for immediate early antigens.</p
The cytomegalovirus (CMV) antigenemia test is a new direct method of diagnosing activeCMV infection....
Recombinant modified vaccinia Ankara- and peptide-based IFN-gamma ELISPOT assays were used to detect...
Vaccines to prevent HCMV infection have primarily included viral antigens identified as key targets ...
During an active infection with human cytomegalovirus (HCMV), viral antigen is consistently present ...
During an active human cytomegalovirus (HCMV) infection, leukocytes harbouring the HCMV lower matrix...
The lower matrix protein (pp65) is a major product of many laboratory strains of cytomegalovirus (CM...
An early antigen of human cytomegalovirus (HCMV) was purified from infected cells as a 72K polypepti...
Objective To determine whether human cytomegalovirus (CMV) matrix protein PP150 is efficiently prese...
Painful peripheral neuropathy (PPN) in HIV-infected patients has been increasingly associated with c...
The characteristics of four human cytomegalovirus (HCMV)-specific monoclonal antibodies as assessed ...
Human monoclonal antibodies specific for human cytomegalovirus (CMV) antigens have been established ...
We have produced amonoclonal antibody against human cytomegalovirus (HCMV) which recognizes a struct...
The characteristics of four human cytomegalovirus (HCMV)-specific monoclonal antibodies as assessed ...
In this work we used PCR to amplify the DNA regions coding for two polypeptides from pUL57 of human ...
The present thesis focuses on the manifestationso f HCMV in the peripheral blood during an active in...
The cytomegalovirus (CMV) antigenemia test is a new direct method of diagnosing activeCMV infection....
Recombinant modified vaccinia Ankara- and peptide-based IFN-gamma ELISPOT assays were used to detect...
Vaccines to prevent HCMV infection have primarily included viral antigens identified as key targets ...
During an active infection with human cytomegalovirus (HCMV), viral antigen is consistently present ...
During an active human cytomegalovirus (HCMV) infection, leukocytes harbouring the HCMV lower matrix...
The lower matrix protein (pp65) is a major product of many laboratory strains of cytomegalovirus (CM...
An early antigen of human cytomegalovirus (HCMV) was purified from infected cells as a 72K polypepti...
Objective To determine whether human cytomegalovirus (CMV) matrix protein PP150 is efficiently prese...
Painful peripheral neuropathy (PPN) in HIV-infected patients has been increasingly associated with c...
The characteristics of four human cytomegalovirus (HCMV)-specific monoclonal antibodies as assessed ...
Human monoclonal antibodies specific for human cytomegalovirus (CMV) antigens have been established ...
We have produced amonoclonal antibody against human cytomegalovirus (HCMV) which recognizes a struct...
The characteristics of four human cytomegalovirus (HCMV)-specific monoclonal antibodies as assessed ...
In this work we used PCR to amplify the DNA regions coding for two polypeptides from pUL57 of human ...
The present thesis focuses on the manifestationso f HCMV in the peripheral blood during an active in...
The cytomegalovirus (CMV) antigenemia test is a new direct method of diagnosing activeCMV infection....
Recombinant modified vaccinia Ankara- and peptide-based IFN-gamma ELISPOT assays were used to detect...
Vaccines to prevent HCMV infection have primarily included viral antigens identified as key targets ...